Patent · US Active

Inhibitor of apoptosis protein (IAP) antagonists

US10047119B2 · kind B2 · utility

4Cited by
6References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2016
Grant dateAug 14, 2018
Priority date—
Expiry dateNov 29, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPB), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.